Monash IVF Group Limited (ASX:MVF)
Australia · Delayed Price · Currency is AUD 0.7450
-0.0100 (-1.32%)
Oct 7, 2026, 4:10 PM AEST
Monash IVF Group Company Description
Monash IVF Group Limited engages in the provision of assisted reproductive genetic and specialist women imaging services in Australia and Southeast Asia.
It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. The company also provides tertiary level prenatal diagnostic, ultrasound, and IVF treatment services.
Monash IVF Group Limited was incorporated in 2014 and is headquartered in Cremorne, Australia.
Monash IVF Group Limited
| Country | Australia |
| Founded | 2014 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 892 |
| CEO | Victoria Atkinson |
Contact Details
Address: 510 Church Street Cremorne, VIC 3121 Australia | |
| Phone | 61 3 9420 8235 |
| Website | monashivfgroup.com.au |
Stock Details
| Ticker Symbol | MVF |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000MVF3 |
| SIC Code | 8060 |
Key Executives
| Name | Position |
|---|---|
| Dr. Victoria Atkinson Afracma, Fracs, Mbbs | MD, Chief Executive Officer and Director |
| Rebecca Redden | Chief Operating Officer |
| Dr. Richard Charles Henshaw M.D. | Executive Director |
| Birol Akdogan | Interim Chief Financial Officer |
| Dr. Deirdre Zander-Fox BSc. (Hons.), Dip. of Mgt, Ph.D. | Chief Scientific Officer |
| Rebecca Dean | Company Secretary and General Counsel |
| Niki Howells-Schramm | Chief People Officer |
| Tedd Fuell | Chief Governance and Risk Officer |
| Dr. Fleur Cattrall | Chief Medical Officer |